Fact CheckerSign in

NCT06779578Recruiting

Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia

The Efficacy and Safety of Fluoroscopic-Guided Bipolar Versus Monopolar Pulsed Radiofrequency for Refractory Trigeminal Neuralgia: An Exploratory Study

Source: ClinicalTrials.gov · Last updated 17 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

A prospective exploratory study aiming at comparing pulsed bipolar versus pulsed unipolar radiofrequency ablation in patients with medically refractory trigeminal neuralgia.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
13 Jan 2025
Start date
1 Jan 2024
Primary completion date
1 Jun 2025
Lead sponsor
Alexandria University
NCT number
NCT06779578

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 1 Jan 2024 to the primary completion date, 1 Jun 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients exposed to previous radiofrequency procedures, as this may impair the nerve response to current PRF.

Other illness

  • Painful trigeminal neuropathy based on the third version of the International Classification of Headache Disorders (ICHD-3).
  • Trigeminal neuralgia comorbid with other atypical facial pain disorders.

Other

  • Trigeminal neuralgia with V1 symptomatic clinical topography.
  • Structural TN e.g., due to vascular compression, posterior fossa tumors, central demyelination, …etc.
  • Patients who refused to participate in the study.

Who the study is looking for

  • Patients with a definitive diagnosis of classical TN based on the third version of the International Classification of Headache Disorders (ICHD-3).
  • Either purely paroxysmal classical TN or classical TN with concomitant chronic pain.
  • Patients with idiopathic TN, with symptomatic clinical topography of V2 and/or V3.
  • Patients with brain magnetic resonance imaging (MRI) unremarkable for structural etiology for the trigeminal pain.
  • Patients with medically refractory TN defined as pain persisting beyond three months at a level of ≥5/10 after monotherapy or polytherapy in appropriate medical doses.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Alexandria University Faculty of Medicine
Coordinator of this site? Confirm its status
AlexandriaEgyptRecruiting
Cairo University Kasr Alainy Faculty of Medicine
Coordinator of this site? Confirm its status
CairoEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.